GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated May 15, 2023, reports on the status of three employee share schemes for the period from November 1, 2022, to April 30, 2023. The filing serves as a Block Listing Six Monthly Return required under UK Listing Rules.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the movement of unallotted securities within specific share incentive plans.
Material Changes in Share Schemes
- 2017 Deferred Annual Bonus Plan: The pool increased by 400,000 shares. During the period, 172,912 shares were issued, resulting in an ending balance of 271,307 unallotted shares.
- Share Save Plan 2012: No increase to the pool was applied for. 563,046 shares were issued, reducing the balance to 558,829 unallotted shares.
- Share Save Plan 2022: The pool was increased by 1,000,000 shares. Only 46 shares were issued, leaving a balance of 999,954 unallotted shares.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is a statutory return regarding share scheme administration.
Key Facts for Investor Verification
- Verify the total number of shares available for future issuance across all three schemes (271,307 + 558,829 + 999,954).
- Confirm the authorization of the 400,000 share increase for the 2017 Deferred Annual Bonus Plan and the 1,000,000 share increase for the 2022 Share Save Plan.
- Note the significant issuance activity in the 2012 Share Save Plan (563,046 shares) compared to the minimal issuance in the 2022 plan (46 shares).